InvestorsHub Logo
icon url

geocappy1

11/07/09 2:53 PM

#44292 RE: Notuncoolish #44291

Exactly! management even stated at the time they had to focus their dollars on Bavi=cancer due to tight funds and a lesser amount on Cotara. Stated they would let Duke and other collaborations carry the ball on viral.

These guys keep beating the same dead horse when know or should know the reasons the comapny has not done all these other trials.
icon url

jessme

11/09/09 9:47 AM

#44297 RE: Notuncoolish #44291

I see a conflict in your statements cooli.


They CAN'T fund every indication at once.

What would your reaction be to a pipe to fund 5 new phase I studies right now


My reaction would be "Lets spend the money to conclude the trials we currently have before jumping into 5 new disease indications."
It seems to me that proving Bavi works and can get FDA approval is more important than seeing how many different trials we can start.